Atrial mechanical hypofunction after electrical cardioversion of persistent or long-lasting persistent atrial fibrillation: a retrospective cohort study
Submitted: October 3, 2019
Accepted: November 24, 2019
Published: December 17, 2019
Accepted: November 24, 2019
Abstract Views: 1066
PDF: 661
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- Maria Teresa La Rovere, Egidio Traversi, Prognostic impact of digoxin use for rate control of atrial fibrillation in patients ≥75 years of age , Monaldi Archives for Chest Disease: Vol. 88 No. 2 (2018)
- Mario Sorice, Francesco Paolo Tritto, Chiara Sordelli, Rosario Gregorio, Luigi Piazza, N-3 polyunsaturated fatty acids reduces post-operative atrial fibrillation incidence in patients undergoing “on-pump†coronary artery bypass graft surgery , Monaldi Archives for Chest Disease: Vol. 76 No. 2 (2011): Cardiac series
- Stefania Angela Di Fusco, Furio Colivicchi, Nadia Aspromonte, Marco Tubaro, Alessandro Aiello, Massimo Santini, Direct oral anticoagulants in patients undergoing cardioversion: insight from randomized clinical trials , Monaldi Archives for Chest Disease: Vol. 87 No. 1 (2017)
- Cesare Greco, Rivaroxaban in non valvular atrial fibrillation: subgroups analysis , Monaldi Archives for Chest Disease: Vol. 82 No. 1 (2014): Cardiac series
- Roberta Ancona, Salvatore Comenale Pinto, Pio Caso, Vito Di Palma, Francesca Pisacane, Alfonso Roberto Martiniello, Cesare Quarto, Nicla De Rosa, Carlo Pisacane, Raffaele Calabrò, Right atrial mass following transcatheter radiofrequency ablation for recurrent atrial fibrillation: thrombus, endocarditis or mixoma? , Monaldi Archives for Chest Disease: Vol. 72 No. 1 (2009): Cardiac series
- Maurizio Giuseppe Abrignani, Furio Colivicchi, Thromboembolic and hemorrhagic risk stratification in patients with atrial fibrillation. Part I: the thromboembolic risk , Monaldi Archives for Chest Disease: Vol. 80 No. 2 (2013): Cardiac series
- Francesco Orso, Riccardo Barucci, Stefania Fracchia, Giulio Mannarino, Alessandra Pratesi, Francesco Fattirolli, Treatment of very old patients with non valvular atrial fibrillation. The valuable opportunity offered by New Oral Anticoagulants, to be cautiously used , Monaldi Archives for Chest Disease: Vol. 80 No. 4 (2013): Cardiac Series
- Giovanni Capobianco, Cognitive impairment in patients with atrial fibrillation: What is the importance of anticoagulant therapy? , Monaldi Archives for Chest Disease: Vol. 88 No. 2 (2018)
- Mauro Di Bari, Alessandra Pratesi, Francesca M. Nigro, Irene Marozzi, Stefano Fumagalli, DAPT plus anticoagulant therapy: The difficult coexistence post-ACS in older patients with atrial fibrillation , Monaldi Archives for Chest Disease: Vol. 88 No. 2 (2018)
- Maurizio Giuseppe Abrignani, Vincenzo Abrignani, Thromboembolic and hemorrhagic risk stratification in patients with atrial fibrillation. Part II: hemorrhagic risk and guidelines recommendations , Monaldi Archives for Chest Disease: Vol. 80 No. 3 (2013): Cardiac series
You may also start an advanced similarity search for this article.